NCT07109726 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT07109726
Title	A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Recruitment	Recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Terremoto Biosciences Inc.
Indications	head and neck squamous cell carcinoma Her2-receptor negative breast cancer lung squamous cell carcinoma breast cancer ovarian cancer cervical cancer Advanced Solid Tumor esophagus squamous cell carcinoma endometrial adenocarcinoma
Therapies	TER-2013 Fulvestrant + TER-2013
Age Groups:	senior \| adult
Covered Countries	USA

NCT07109726
Clinical Trial Detail